Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | TAVO412 |
Trade Name | |
Synonyms | TAVO 412|TAVO-412 |
Drug Descriptions |
TAVO412 is a trispecific antibody that targets MET, EGFR, and VEGF, potentially resulting in inhibition of tumor growth (Cancer Res (2023) 83 (5_Supplement): P2-24-05). |
DrugClasses | EGFR Antibody 60 MET Antibody 31 VEGF Antibody 12 |
CAS Registry Number | NA |
NCIT ID | C192641 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
TAVO412 | TAVO412 | 0 | 1 |